CGEN vs OABI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

CGEN

39.5
AI Score
VS
CGEN Wins

OABI

36.8
AI Score

Investment Advisor Scores

CGEN

40score
Recommendation
EXTENDED

OABI

37score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CGEN OABI Winner
Forward P/E 12.3609 0 Tie
PEG Ratio 1.2874 0 Tie
Revenue Growth 107.0% 244.2% OABI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.5/100 36.8/100 CGEN
Profit Margin 47.6% -115.1% CGEN
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED EXTENDED Tie

Relative Price Performance (Last 90 Days)

CGEN 1M: +11.8% · 3M: +0.2% OABI 1M: +112.3% · 3M: +69.8%

Current Technical Phase

CGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $2.62

OABI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 89

RSI (14): 89.3 · Price: $4.33

Fundamentals Snapshot

Metric CGEN OABI
Market Cap
Forward P/E -7.1 -14.7
Trailing P/E 7.0
Revenue (TTM)
Revenue Growth 1.1% 2.4%
Gross Margin 0.9% 1.0%
Operating Margin -3.4% -0.5%
EPS 0.38 -0.36
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.